Curcumin and its Derivatives Targeting Multiple Signaling Pathways to Elicit Anticancer Activity : A Comprehensive Perspective

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

The uncontrolled growth and spread of aberrant cells characterize the group of disorders known as cancer. According to GLOBOCAN 2022 analysis of cancer patients in either developed countries or developing countries the main concern cancers are breast cancer, lung cancer, and liver cancer which may rise eventually. Natural substances with dietary origins have gained interest for their low toxicity, anti-inflammatory, and antioxidant effects. The evaluation of dietary natural products as chemopreventive and therapeutic agents, the identification, characterization, and synthesis of their active components, as well as the enhancement of their delivery and bioavailability, have all received significant attention. Thus, the treatment strategy for concerning cancers must be significantly evaluated and may include the use of phytochemicals in daily lifestyle. In the present perspective, we discussed one of the potent phytochemicals, that has been used over the past few decades known as curcumin as a panacea drug of the "Cure-all" therapy concept. In our review firstly we included exhausted data from in-vivo and in-vitro studies on breast cancer, lung cancer, and liver cancer which act through various cancer-targeting pathways at the molecular level. Now, the second is the active constituent of turmeric known as curcumin and its derivatives are enlisted with their targeted protein in the molecular docking studies, which help the researchers design and synthesize new curcumin derivatives with respective implicated molecular and cellular activity. However, curcumin and its substituted derivatives still need to be investigated with unknown targeting mechanism studies in depth.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - year:2023

Enthalten in:

Current medicinal chemistry - (2023) vom: 22. Mai

Sprache:

Englisch

Beteiligte Personen:

Fatima, Firdous [VerfasserIn]
Chourasiya, Nikhil Kumar [VerfasserIn]
Mishra, Mitali [VerfasserIn]
Kori, Shivam [VerfasserIn]
Pathak, Sandhya [VerfasserIn]
Das, Ratnesh [VerfasserIn]
Kashaw, Varsha [VerfasserIn]
Iyer, Arun K [VerfasserIn]
Kashaw, Sushil Kumar [VerfasserIn]

Links:

Volltext

Themen:

Cancer
Curcumin
Journal Article
Molecular docking
Phytochemicals
Signaling pathway
Turmeric

Anmerkungen:

Date Revised 24.05.2023

published: Print-Electronic

Citation Status Publisher

doi:

10.2174/0929867330666230522144312

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357240790